Aug 2026· Journal of Chemical Information and Modeling· Vol 66 17, pp.
11348-11360
· 0 citations· 43 references
Medicine
TL;DR
LinkLlama is presented, a fine-tuned Meta Llama 3 model that bridges the gap between text-based generation and 3D spatial awareness, offering a highly controllable and chemically robust framework to accelerate linker design and drug discovery in general.
Abstract
Fragment-based drug discovery (FBDD) relies heavily on the design of chemically viable linkers to connect fragments binding to different pocket regions into potent lead molecules. While recent generative models have advanced spatial fragment linking, they frequently produce linkers characterized by high torsional strain and non-drug-like motifs. In this work, we present LinkLlama, a fine-tuned Meta Llama 3 model that bridges the gap between text-based generation and 3D spatial awareness. By accepting natural language prompts that specify geometric constraints, such as distances and angles, alongside physicochemical targets like Lipinski's rules and rotatable bond limits, LinkLlama generates highly tailored molecules for the input fragments. Leveraging the inherent chemical grammar captured through supervised fine-tuning on a curated corpus of drug-like molecules from ChEMBL, the model prioritizes chemical validity without requiring complex reinforcement learning loops. Benchmarking on the ZINC and HiQBind data sets demonstrates that LinkLlama maintains competitive geometric fidelity compared to strictly 3D-aware models while achieving a 2-fold increase in the proportion of chemically reasonable designs. This rising success rate, jumping from 35% to over 80%, is defined by strict adherence to comprehensive structural filters including PAINS, non-drug-like chemical patterns, and complex ring systems. We further illustrate the model's versatility through prospective case studies in novel small-molecule scaffold hopping and PROTAC linker design, validated via molecular docking and molecular dynamics simulations against known crystal poses. Ultimately, LinkLlama demonstrates that large language models can overcome the structural pitfalls of purely 3D-generative methods, offering a highly controllable and chemically robust framework to accelerate linker design and drug discovery in general.
LDDM (Large Drug Discovery Model) is introduced, a generative framework that supports a range of drug discovery tasks, including constrained and unconstrained docking, fragment linking and growing, and de novo design, and a programmable design algorithm that enables accurate design of synthetically accessible compounds...
Ilia Igashov, Arne Schneuing, Adrian W. Dobbelstein et al.· bioRxiv· 0 citations
LGBind is introduced, a structure-guided deep learning framework for generalized, ligand-conditioned binding site identification and demonstrates profound robustness and generalization in predicting novel ligand-target interactions, and demonstrates remarkable versatility.
Yun-Feng Li, Xing-Yu Liu, Yi-Jia Liu et al.· European journal of medicina...· 0 citations
EvoBind-multimer is presented, a deep learning framework for the de novo design of molecular glues directly from protein sequences that generates small macrocyclic peptides that bridge user-defined protein pairs without requiring prior interface knowledge or existing ligands.
Andrä Brunner, Krzysztof Wierbiłowicz, Diandra Daumiller et al.· bioRxiv· 0 citations
LinkerBridge is proposed, an equivariant framework that unifies biochemical semantics with physical constraints through two innovations: a Contextual Interaction-Aware Representation module that internalizes pre-existing bio-chemical semantics and a Differentiable Physical Guidance mechanism derived from Van der Waals...
Meng-Wei Sun, Chengwei Ai, Xiao-Yi Liu et al.· Proceedings of the Thirty-Fi...· 0 citations
Reticular chemistry has enabled the synthesis of tens of thousands of metal–organic frameworks (MOFs), yet the discovery of new materials still relies largely on intuition-driven linker design and iterative experimentation. As a result, researchers explore only a small fraction of the vast chemical space accessible to...
Dhruv Menon, Vivek Singh, Xu Chen et al.· Journal of the American Chem...· 0 citations
Abstract Motivation Designing molecules with predefined properties remains a critical yet challenging task in drug discovery. Recent advances in deep learning have demonstrated strong potential in accelerating the identification of novel compounds with desired properties and activities. However, the implementation and...